Cargando…
Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma
The incidence rate of melanoma is dramatically increasing worldwide, raising it to the fifth most common cancer in men and the sixth in women currently. Resistance generally occurs to the agents used in chemotherapy; besides their high toxicity destroys the normal cells. This study reviewed a detail...
Autores principales: | Saeidi, Zahra, Giti, Rashin, Rostami, Mehdi, Mohammadi, Farhad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676549/ https://www.ncbi.nlm.nih.gov/pubmed/38022807 http://dx.doi.org/10.34172/apb.2023.070 |
Ejemplares similares
-
Nanotechnology-based drug delivery systems
por: Suri, Sarabjeet Singh, et al.
Publicado: (2007) -
Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review
por: Rigon, Roberta Balansin, et al.
Publicado: (2015) -
Transdermal Delivery of Therapeutic Compounds With Nanotechnological Approaches in Psoriasis
por: Li, Ning, et al.
Publicado: (2022) -
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
por: Fonseca-Santos, Bruno, et al.
Publicado: (2015) -
Transdermal Drug Delivery Systems and Their Use in Obesity Treatment
por: Li, Zhiguo, et al.
Publicado: (2021)